JP2005517414A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517414A5
JP2005517414A5 JP2003568411A JP2003568411A JP2005517414A5 JP 2005517414 A5 JP2005517414 A5 JP 2005517414A5 JP 2003568411 A JP2003568411 A JP 2003568411A JP 2003568411 A JP2003568411 A JP 2003568411A JP 2005517414 A5 JP2005517414 A5 JP 2005517414A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
calgranulin
amount
inflammatory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003568411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517414A (ja
JP5487404B2 (ja
Filing date
Publication date
Priority claimed from US10/077,600 external-priority patent/US20030175713A1/en
Application filed filed Critical
Publication of JP2005517414A publication Critical patent/JP2005517414A/ja
Publication of JP2005517414A5 publication Critical patent/JP2005517414A5/ja
Application granted granted Critical
Publication of JP5487404B2 publication Critical patent/JP5487404B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003568411A 2002-02-15 2003-02-17 カルグラヌリンｃを用いた炎症性疾患の診断方法 Expired - Fee Related JP5487404B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/077,600 2002-02-15
US10/077,600 US20030175713A1 (en) 2002-02-15 2002-02-15 Method for diagnosis of inflammatory diseases using CALGRANULIN C
PCT/EP2003/001575 WO2003069341A2 (en) 2002-02-15 2003-02-17 Method of diagnosis of inflammatory diseases using calgranulin c

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010244271A Division JP5650985B2 (ja) 2002-02-15 2010-10-29 カルグラヌリンｃを用いた炎症性疾患の診断方法

Publications (3)

Publication Number Publication Date
JP2005517414A JP2005517414A (ja) 2005-06-16
JP2005517414A5 true JP2005517414A5 (enExample) 2006-04-06
JP5487404B2 JP5487404B2 (ja) 2014-05-07

Family

ID=27732684

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003568411A Expired - Fee Related JP5487404B2 (ja) 2002-02-15 2003-02-17 カルグラヌリンｃを用いた炎症性疾患の診断方法
JP2010244271A Expired - Fee Related JP5650985B2 (ja) 2002-02-15 2010-10-29 カルグラヌリンｃを用いた炎症性疾患の診断方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010244271A Expired - Fee Related JP5650985B2 (ja) 2002-02-15 2010-10-29 カルグラヌリンｃを用いた炎症性疾患の診断方法

Country Status (8)

Country Link
US (3) US20030175713A1 (enExample)
EP (1) EP1474689B1 (enExample)
JP (2) JP5487404B2 (enExample)
AU (1) AU2003212245A1 (enExample)
CA (1) CA2474890A1 (enExample)
DK (1) DK1474689T3 (enExample)
ES (1) ES2394962T3 (enExample)
WO (1) WO2003069341A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
WO2004043238A2 (en) * 2002-11-14 2004-05-27 Ciphergen Biosystems, Inc. Biomarkers for intra-amniotic inflammation
ATE458201T1 (de) 2003-12-23 2010-03-15 Hoffmann La Roche Methode zur beurteilung von rheumatoider arthritis durch bestimmung von anti-ccp und interleukin 6
JP4868378B2 (ja) * 2004-11-19 2012-02-01 株式会社明治 炎症性腸疾患治療薬
KR101147586B1 (ko) * 2006-05-19 2012-08-23 에프. 호프만-라 로슈 아게 결장직장암에 대한 마커로서 단백질 ｓ100ａ12 의 용도
DE102007036678B4 (de) * 2007-08-03 2015-05-21 Sirs-Lab Gmbh Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion
WO2009049257A2 (en) * 2007-10-11 2009-04-16 Cardio Dx, Inc. Predictive models and methods for diagnosing and assessing coronary artery disease
CA2702533A1 (en) * 2007-10-19 2009-04-23 Erac As Edta resistant s100a12 complexes (erac)
GB0922006D0 (en) * 2009-12-17 2010-02-03 Genome Res Ltd Diagnostic
WO2011146479A1 (en) * 2010-05-18 2011-11-24 The Texas A&M University System Method and composition for the diagnosis and monitoring of inflammatory diseases
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
US9678084B2 (en) * 2011-06-04 2017-06-13 Rochester General Hospital Research Institute Compositions and methods related to S100A12
WO2013167727A2 (en) 2012-05-11 2013-11-14 Westfaelische Wilhelms-Universitaet Muenster Method for determining arthritis relapse risk
EP3487874A1 (en) 2016-07-20 2019-05-29 Westfälische Wilhelms-Universität Münster Complex-specific standardization of immunological methods for the quantification of s100a12
US11287396B2 (en) 2020-06-05 2022-03-29 Princeton Biochemicals, Inc. Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
JPH08238091A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
EP0731166A3 (en) * 1995-03-06 1997-12-29 Tonen Corporation Novel calcium-binding proteins
US5976832A (en) * 1995-03-06 1999-11-02 Tonen Corporation DNA encoding novel calcium-binding proteins
WO2000020621A1 (en) * 1998-10-06 2000-04-13 The Trustees Of Columbia University In The City Of New York Extracellular novel rage binding protein (en-rage) and uses thereof
US7081241B1 (en) * 1998-10-06 2006-07-25 The Trustees Of Columbia University In The City Of New York Extracellular rage binding protein (EN-RAGE) and uses thereof
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
WO2001086002A2 (en) * 2000-05-09 2001-11-15 Genetics Institute, Llc Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
AU2001292846A1 (en) * 2000-09-20 2002-04-29 Surromed, Inc. Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders
WO2002048310A2 (en) * 2000-12-15 2002-06-20 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C

Similar Documents

Publication Publication Date Title
JP2005517414A5 (enExample)
EP0756708B1 (en) Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
ES2356481T3 (es) Procedimiento para diagnosticar poliquistosis renal.
US20110189698A1 (en) Protein Biomarkers and Methods for Diagnosing Kawasaki Disease
US20040115728A1 (en) Detecting lipocalin
RU2009141523A (ru) Биомаркеры для рассеянного склероза
CN103380379B (zh) 尿路感染的诊断方法
US20130224772A1 (en) Method for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells
ES2911270T3 (es) Composición para diagnosticar enfermedades infecciosas o complicaciones infecciosas mediante el uso de triptofanil-arnt sintetasa y método para detectar el marcador de diagnóstico
JP2016502095A (ja) 特異的抗体プロファイルを使用した自己免疫疾患の診断
EP2628006A2 (en) Markers of primary graft dysfunction
RU2018103933A (ru) Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом
CN112920275B (zh) 可特异性结合sST2的结合蛋白、试剂和试剂盒
KR102426782B1 (ko) SARS-CoV-2 RBD 항원 특이적 항체를 포함하는 진단용 조성물 또는 키트
JP2011502244A5 (enExample)
US20110287458A1 (en) Method and composition for the diagnosis and monitoring of inflammatory diseases
JP5961608B2 (ja) ＥｐｈＡ４細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
US20230003742A1 (en) Non-invasive assay for detecting and monitoring systemic inflammation
JP6312311B2 (ja) 気道内炎症検査用バイオマーカー
CN109997043A (zh) 护理点测定法
WO2023275235A1 (en) Method and means for diagnosis of spondyloarthritis
CN115605758A (zh) 使用蛋白质-精氨酸脱亚胺酶1(pad1)自身抗原诊断和评估类风湿性关节炎的组合物和方法
JP2010507780A (ja) Ｂ型インフルエンザウイルスの検出
KR20170076611A (ko) 뇨 대사체에서 발굴된 폐렴연쇄상구균 유래 ABC-NBD, pstS, csrR 단백질을 이용한 진단방법
MX2008010297A (en) Detection of cancer by elevated levels of bcl-2